New Hope Against Diseases Marked by Progressive Scarring of Lung Tissue
The Pharma Data
JANUARY 15, 2021
15, 2021 — An inhaled medication might make every day physical activity a bit easier for patients with serious scarring of the lungs, a new clinical trial finds. Food and Drug Administration to approve Tyvaso for ILD patients. The trial, funded by Tyvaso maker United Therapeutics, involved 326 patients.
52 
Let's personalize your content